AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma
Adenoid cystic carcinoma (ACC) presents crack top frock a formidable challenge due to its slow growth, late-stage metastasis, and resistance to conventional therapies.Targeting the AXL receptor, implicated in aggressive tumor behavior and therapeutic resistance, offers a promising therapeutic avenue.Several studies demonstrate that AXL inhibition s